DrReddy's, Sun Pharma among 14 firms probed by US over drug price
India's pharma majors Dr Reddy's and Sun Pharma are among 14 drug makers which are being probed by the US Congress over price escalation of generic drugs.
Oct 08, 2014, 21:06 PM IST
NPPA order may not impact much, seeking legal advice: Reddy's
The recent National Pharmaceutical Pricing Authority (NPPA) order bringing in some more medicines under control may not have much impact on city-based drug maker Dr Reddy's Laboratories in terms of product pricing, according to a senior company official.
Jul 16, 2014, 16:25 PM IST
Dr Reddy's Lab launches duloxetine delayed-release capsules
Drug maker Dr Reddy's Laboratories has launched duloxetine delayed-release capsules USP 20 mg, 30 mg and 60 mg in the US market.
Jun 27, 2014, 15:46 PM IST
Dr Reddy's launches generic Paricalcitol capsules in US market
Drug firm Dr Reddy's Laboratories has launched generic Paricalcitol capsules used for treating secondary hyperparathyroidism associated with chronic kidney disease in the American market, following approval by the US health regulator.
Jun 25, 2014, 13:32 PM IST
